NPI Details
Sandy W. Doti, MD is an internal medicine in Middletown, NY with 30 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Sandy W. Doti, MD NPI is 1477545085. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: STATE UNIVERSITY OF NEW YORK DOWNSTATE MEDICAL CENTER
Graduation Year:1996
The provider's business location address is:
155 CRYSTAL RUN RD
MIDDLETOWN, NY
ZIP 10941-028
Phone: (845) 703-6999
Fax: (845) 703-6297
The NPI 1477545085 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
- Hemoglobin a1c level (HCPCS:83036)
- Vitamin d-3 level (HCPCS:82306)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes (HCPCS:99458)
- Influenza vaccine split virus, preservative free (HCPCS:90662)
- Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
- Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
- Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days (HCPCS:99454)
- Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
- Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
- Urine microalbumin (protein) level (HCPCS:82043)
- Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
- Administration of pneumococcal vaccine (HCPCS:G0009)
- Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
- Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
- Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
- Psa (prostate specific antigen) measurement, total (HCPCS:84153)
- Thyroxine (thyroid chemical), free (HCPCS:84439)
- Assessment of emotional or behavioral problems (HCPCS:96127)
- Automated urinalysis test (HCPCS:81003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
The enumeration date for this NPI number is 8/19/2005 and was last updated on 8/11/2020.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | 207425 | NEW YORK | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 01961540 | MEDICAID | NEW YORK | |
